Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
11.18
-0.02 (-0.17%)
May 14, 2026, 10:47 AM EDT - Market open

Korro Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.846.392.27--14.07
Revenue Growth (YoY)
-20.31%181.46%----61.96%
Gross Profit
3.846.392.27--14.07
Selling, General & Admin
27.8128.1630.5527.2816.837.18
Research & Development
58.7965.5863.6457.2542.260.92
Other Operating Expenses
-34.51----
Total Operating Expenses
86.6128.2594.1884.535998.1
Operating Income
-117.27-121.86-91.91-84.53-59-84.03
Interest Income
-----0.4
Interest Expense
------0.76
Other Non-Operating Income (Expense)
4.515.238.473.390.980.23
Total Non-Operating Income (Expense)
4.515.238.473.390.98-0.14
Pretax Income
-112.77-116.62-83.44-81.15-58.02-84.67
Provision for Income Taxes
-0.73-0.64-0.14-0.030.01-0.02
Net Income
-113.5-117.26-83.58-81.17-58.03-84.69
Net Income to Common
-113.5-117.26-83.58-81.17-58.03-84.69
Shares Outstanding (Basic)
1099211
Shares Outstanding (Diluted)
1099211
Shares Change (YoY)
7.44%5.32%483.30%137.08%--
EPS (Basic)
-11.67-12.48-9.37-53.08-227.42-4.94
EPS (Diluted)
-11.67-12.48-9.37-53.08-227.42-4.94
Shares Outstanding
14.429.429.388.020.710.69
Free Cash Flow
-70.6-79.08-77.98-75.12-58.86-78.97
Free Cash Flow Per Share
-7.10-8.42-8.74-49.12-91.24-122.43
Gross Margin
100.00%100.00%100.00%--100.00%
Operating Margin
-3052.34%-1906.37%-4047.12%---597.32%
Profit Margin
-2954.14%-1834.48%-3680.36%---601.98%
FCF Margin
-1837.66%-1237.16%-3433.55%---561.37%
EBITDA
-113.84-117.58-88.35-80.9-56.49-81.26
EBITDA Margin
-2962.94%-1839.41%-3890.14%---577.60%
EBIT
-117.27-121.86-91.91-84.53-59-84.03
EBIT Margin
-3052.34%-1906.37%-4047.12%---597.32%
Effective Tax Rate
0.65%0.55%0.17%0.03%-0.02%0.02%
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q